Samina Ajaz Hussain

3PUBLICATIONS

10CO-AUTHORS

PharmacogenomicsPharmaceutical delivery technologies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 07, 2026

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.

|Nov 11, 2025

Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes.

Sean Wharton, Carel W le Roux, Biykem Bozkurt

|Nov 04, 2025

Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1).

Carel W le Roux, Sean Wharton, Biykem Bozkurt

Pageof 1

Frequent Collaborators

3 joint publications

Carel W le Roux

3 joint publications

Biykem Bozkurt

3 joint publications

Lee M Kaplan

2 joint publications

Sean Wharton

2 joint publications

Elke Platz

2 joint publications

Gabriele Bleckert

2 joint publications

Martina Brueckmann

1 joint publications

Elena Startseva

1 joint publications

Daniel F Mazo

1 joint publications

Arun J Sanyal

Frequent Collaborators

3 joint publications

Carel W le Roux

3 joint publications

Biykem Bozkurt

3 joint publications

Lee M Kaplan

2 joint publications

Sean Wharton